EMEA-000027-PIP01-07 - paediatric investigation plan

Tifacogin

Key facts

• Active Substance:
  Tifacogin
• Therapeutic area:
  Infectious diseases
• Decision number:
  P/33/2008
• PIP number:
  EMEA-000027-PIP01-07
• Pharmaceutical form(s):
  Solution for infusion
• Condition(s) / indication(s):
  Septicaemia
• Route(s) of administration:
  Intravenous use
• Contact for public enquiries:

  Novartis Europharm Limited

  E-mail: [e-mail]; Tel. [phone]

• Decision type:
  P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
• Decision date:
  24/06/2008

Decision

P/33/2008: European medicines agency decision of 24 June 2008 on the application for agreement of a Paediatric Investigation Plan for tifacogin EMEA-000027- PIP01-07 in accordance with Regulation (EC) No 1901/2006

AdoptedReference Number: EMEA/311526/2008